Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.

[1]  J. Deakin,et al.  THE EFFECTS OF PUTATIVE 5‐HYDROXYTRYPTAMINE ANTAGONISTS ON THE BEHAVIOUR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L‐TRYPTOPHAN OR TRANYLCYPROMINE AND L‐DOPA TO RATS , 1978, British journal of pharmacology.

[2]  G. Di Chiara,et al.  Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. , 1987, European journal of pharmacology.

[3]  A. Barnett,et al.  Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. , 1984, Life sciences.

[4]  H. Fibiger.  Drugs and reinforcement mechanisms: a critical review of the catecholamine theory. , 1978, Annual review of pharmacology and toxicology.

[5]  E. Rolls,et al.  Noradrenaline, dopamine, and brain-stimulation reward. , 1974, Pharmacology, biochemistry, and behavior.

[6]  F. V. Defeudis,et al.  CNS receptors : from molecular pharmacology to behavior , 1983 .

[7]  R. Wise,et al.  Neural substrates of opiate reinforcement , 1983, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  D A Overton,et al.  Experimental methods for the study of state-dependent learning. , 1974, Federation proceedings.

[9]  D. Kooy,et al.  Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning , 1985, Pharmacology Biochemistry and Behavior.

[10]  N. Fujita,et al.  Multiple postsynaptic dopamine receptors and behavioral manifestation , 1982, Pharmacology Biochemistry and Behavior.

[11]  R. Wise,et al.  Heroin reward is dependent on a dopaminergic substrate. , 1981, Life sciences.

[12]  D. Fage,et al.  Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum. , 1986, European journal of pharmacology.

[13]  M. Memo,et al.  D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP , 1986, Neuroscience Letters.

[14]  R. Wise,et al.  Action of drugs of abuse on brain reward systems: An update with specific attention to opiates , 1982, Pharmacology Biochemistry and Behavior.

[15]  D. German,et al.  Catecholamine systems as the neural substrate for intracranial self-stimulation: a hypothesis. , 1974, Brain research.

[16]  J. C. Stoof,et al.  The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro. , 1984, European journal of pharmacology.

[17]  B. Costall,et al.  Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. , 1976, European journal of pharmacology.

[18]  C. Haertzen,et al.  The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). , 1967, The Journal of pharmacology and experimental therapeutics.

[19]  G. Di Chiara,et al.  Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. , 1986, The Journal of pharmacology and experimental therapeutics.

[20]  G. Gessa,et al.  Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. , 1984, European journal of pharmacology.

[21]  I. Stolerman.  Motivational effects of opioids: Evidence on the role of endorphins in mediating reward or aversion , 1985, Pharmacology Biochemistry and Behavior.

[22]  J. Hyttel.  SCH 23390 - the first selective dopamine D-1 antagonist. , 1983, European journal of pharmacology.

[23]  R. Wise.  Catecholamine theories of reward: A critical review , 1978, Brain Research.

[24]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[25]  H. Schoemaker,et al.  5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain. , 1984, European journal of pharmacology.

[26]  C. Gallistel,et al.  Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation , 1983, Pharmacology Biochemistry and Behavior.

[27]  I. Creese,et al.  Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. , 1986, The Journal of pharmacology and experimental therapeutics.

[28]  R. Beninger,et al.  Dopaminergic substrates of cocaine-induced place conditioning , 1986, Brain Research.

[29]  C. Saller,et al.  D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo. , 1986, The Journal of pharmacology and experimental therapeutics.

[30]  T. Shippenberg,et al.  Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists , 1987, Brain Research.

[31]  S. O'Connor,et al.  The pharmacology of sulpiride--a dopamine receptor antagonist. , 1982, General pharmacology.

[32]  A. Barnett,et al.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. , 1983, The Journal of pharmacology and experimental therapeutics.